The results of the shortage or lack of insurance coverage for generic Adderall XR forced many people to seek out name-brand Adderall XR, which, in turn, ran out. Then people, desperate for any ADHD medication, sought out the generic instant release amphetamine salts (formally Adderall). The increased demand on instant release dried up the supplies pretty quickly, and soon ADHD sufferers everywhere were unable to find any form of their medication. Luckily, Shire had magically possessed enough amphetamines from their DEAquota to produce plenty of their new ADHD medication, Vyvanse. In fact, Shire doubled its third quarter profits from 2010 to 2011, with most of that increase resulting from Vyvanse sales. During this time, coinciding nicely with the Adderall shortage, Shire hiked the price of Vyvanse.
Read More | “Anatomy of the great Adderall drought” | Kelly Bourdet | Vice